Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-25 @ 2:20 AM
NCT ID:
NCT01704534
Eligibility Criteria:
Inclusion Criteria:
* 18 years or older
* Hidradenitis suppurativa Hurley stage II or III
* No response to conventional local and oral antibiotics, or immunnesuppressive medication, or TNF-alpha inhibitors or surgery
* The patient has to be able to complete a dutch questionnaire
* Informed consent must be obtained
Exclusion Criteria:
* Not able to complete a Dutch questionnaire
* Pregnancy or breast feeding
* Active hepatitis B or C infection, HIV or tuberculosis
* Treatment with biologics or other immunosuppressive medicine in the previous 3 months
* Malignancies in the last 10 years with the exception of basal cell carcinoma
* Demyelinating disorders
* Heart failure
* Known allergy to ustekinumab or to its preservatives
* Live vaccins in the next 3 months Sever liver or renal failure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01704534
Study Brief:
Protocol Section:
NCT01704534